dihydroergotamine
Selected indexed studies
- Dihydroergotamine (DHE) - Then and Now: A Narrative Review. (Headache, 2020) [PMID:31737909]
- Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults. (Expert Rev Neurother, 2024) [PMID:38655598]
- Relationship of dihydroergotamine pharmacokinetics, clinical efficacy, and nausea-A narrative review. (Headache, 2025) [PMID:39601088]
_Worker-drafted node — pending editorial review._
Connections
dihydroergotamine is a side effect of
Sources
- Dihydroergotamine (DHE) - Then and Now: A Narrative Review. (2020) pubmed
- Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults. (2024) pubmed
- Relationship of dihydroergotamine pharmacokinetics, clinical efficacy, and nausea-A narrative review. (2025) pubmed
- The pharmacology of ergotamine and dihydroergotamine. (1997) pubmed
- Ergotamine and dihydroergotamine: a review. (2003) pubmed
- Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature. (2005) pubmed
- Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment. (2012) pubmed
- Dihydroergotamine: role in the treatment of migraine. (2009) pubmed
- Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. (2003) pubmed
- Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. (2006) pubmed